Introduction
Anti-arrhythmic surgery to treat atrial fibrillation (AF) is predominantly combined with mitral valve surgery. The advent of alternative sources of energy, such radiofrequency ablation, facilitated the surgical technique to perform a concomitant anti-arrhythmic procedure (1) . We used the saline irrigated cooled tip monopolar radiofrequency ablation (SICTRA), which was applied endocardially, to create linear lesions in order to abolish AF. Our results in mitral valve surgery patients were encouraging with a sinus rhythm rate of 76-80% at 12 months follow-up (2;3). Therefore, we extended our indication to non-mitral valve diseased patients such as AVR and CABG procedures. However, the atria in this subset of patients had to be opened intentionally to perform the various intra-atrial lesions. Whether an extension of the operative procedure to treat AF, in this subset of patients, was justified will eventually be determined by the induced additional morbidity and mortality, balanced against the success of the obtained sinus rhythm (SR) conversion rate. The aim of this study was to assess the efficacy of concomitant antiarrhythmic surgery, using SICTRA, in non-mitral valve patients compared to mitral valve patients.
Patients and Methods

Methods
This study was approved by the local ethical committee at the Bergmannsheil University Hospital Bochum. Between April 1997 and December 2003, 128 patients with a documented permanent atrial fibrillation had a concomitant anti-arrhythmic procedure using monopolar endocardial radiofrequency ablation. Patients who had combined valves with or without CABG procedures or those who experienced preoperative haemodynamic instability were excluded from this study. The patients' characteristics are shown in table 1. Informed consent was obtained from each patient. The definition of permanent AF was in accordance with the guidelines the AHA/ESC. Each patient had a preoperative standard-and extended ECG registration. If, on the ECG, an episode of saw-tooth atrial wave pattern or an episode of regularity was observed, then a bi-atrial lesion pattern was conducted to abolish a possible right atrial flutter. Otherwise, only a left atrial lesion pattern was performed. A preoperative transthoracic echocardiography was performed, on admission to our department. The left ventricular ejection fraction (LVEF) was determined and the size of the left atrium was measured in the parasternal long axis view with M-mode. Our operative technique, including the creation of the ablation lines, has been previously described in detail (2;3).
Postoperative Care
The patients were kept on AAI or DDD pacing if the heart rate was below 75 beats per minute during the first 7 postoperative days. The first 28 patients received metoprolol 40 mg twice a day on the l sl postoperative day (pod), 80 mg twice a day on the 2 nd pod and 160 mg twice a day after the 7 th pod. This medication protocol was changed after the 28' 1 ' patient, because 2 patients experienced a sudden cardiac death during late follow-up. We changed to metoprolol 47.5 mg per day starting on the T'pod. The dose was increased to 95 mg retard per day on the 3 rd postoperative day and eventually to 190 mg per day if no Brady arrhythmia was noticed. The first 50 patients had a cardioversion at the 12 th pod and the 3 rd postoperative month. But this strategy was abandoned, because no beneficial effect, in our opinion, was noticed. Therefore, no cardioversion was performed before the 6 lh postoperative month in the last 74 patients. If the patient remained in AF after the 6 th postoperative month than one cardioversion with 240 to 360 Joule was performed. All patients received coumadine, starting on the 1 st pod, targeting an INR value around 2.2 for solitary CABG patients and 2.8 to 3.5 for valve patients. Coumadine was continued for at least 6 months and was stopped if a stable SR was documented on a 24-hour Holter ECG and if an atrial contraction was visualized on echo Doppler examination.
Follow-up
Primary rhythm endpoint was a stable SR, defined as 95-100% SR on a 24-hour Holter registration. Secondary endpoint was atrial contraction, visualized as an A-wave on an echo Doppler parasternal long axis image using M mode or on a four chamber apical view. Data acquisition was obtained for each patient on the I s ' pod, 12 lh pod (pre-discharge) and after the Primary endpoint for follow-up was death or last patients' visit. Secondary endpoints were postoperative complications including a temporary respiratory insufficiency, low cardiac output, myocardial infarct, cerebral event, wound infection, rethoracotomy, and sternal dehiscence. Survival information was complete.
Statistic analysis
Continuous variables with a normal distribution were compared with the student's t-test. The binary logistic regression was used to assess predictors of postoperative SR. Categorical data comparisons were made with the Fisher exact test. The cumulative survival-and the postoperative sinus rhythm rates were calculated according to the Kaplan-Meier method. Descriptive statistics were expressed as means +/-SD. Differences were calculated with the log-rank test. P values <0.05 were considered significant. The SPSS 11.5 for Windows statistic software program was used for analysis. 61 (64) 93 (23) 58 ( 
Discussion
The incidence of AF in surgically treated mitral valve diseased patients varies between 26% and 58% (4-6). AF in aortic valve diseased patients, who are over 70 years of age, is about 16% (115/7171) (7).The incidence of AF in association with coronary artery disease is much lower, less than 2%. Nevertheless, the presence of AF in CABG patients was associated with older age, male gender and congestive heart failure (8;9). In our surgical practice the absolute number of CABG patients exceeds the number of mitral valve diseased patients, indicating that the total number of CABG with AF is steadily growing and momentarily has reached 25% (59/230) of our surgical AF practice. Mitral valve diseased patients with AF constituted 36.5% (84/230) of our practice. The international literature revealed a distinct effect of AF on the event-free survival and the overall survival. Kvidal reported decreased event-free-survival rates at 5 and 10 years after AVR. The risk for at least one hemorrhages, due to coumadine use, was increased in patients with a pre-operative history of atrial fibrillation (10;11). Bessel and associates observed a reduced long-term survival in 1322 AVR patients (12) . Quader reported that preoperative AF was a high risk factor in CABG patients, which substantially reduced survival at 30 days, 5 and 10 years compared to patients without AF; 97% versus 99%, 68% versus 85%, and 42% versus 66%. (13) . So, AF in non-mitral valve surgery is associated with increased morbidity and mortality. Whether a postoperative SR conversion will positively influence the postoperative morbidity and mortality can only be evaluated if our present surgical technique, to convert permanent AF into SR, proves to be efficacious.
Sinus rhythm and atrial contraction
In this series, the cumulative postoperative SR percentages for the group I and II patients at 12 months were 71% versus 79%. So, the type of surgical pathology, in our study, apparently did not adversely affect the success rate. Harada and associates, who performed intraoperative electrophysiological mapping in mitral valve patients and a single CABG patient with chronic atrial fibrillation found similar regular and repetitive activation originating from the left atrial appendage and/or the left pulmonary vein orifice. All patients were successfully ablated with cryoablation on the epicardium of the left atrial appendage (15) (16) (17) . Konings and associates, however, suggested that perpetuation of the fibrillatory process has several aspects which potentially have a relationship with the type of cardiac pathology (18) . So, the electrophysiological pattern of AF for mitral diseased-and CABG patients tend to have an overlap. The mean size of the left atrium in the mitral valve patients was 6.5 millimeters larger than in the CABG and AVR patients; 52.4 versus 45.9 millimeters. So, the extent of electrical-and mechanical remodeling of the left atrium was probably more profound in the mitral valve group than in the AVR and CABG group (19) . This would theoretically adversely affect the SR conversion rate, although the difference in SR conversion rate for both groups was not statistically different; 71% versus 79%. In our series 65.6% and 68.3% of the group I and II patients, who had a stable SR showed a biatrial contraction. Therefore, the coumadine was stopped 6 months postoperatively in all these patients who had a CABG, a mitral valve plasty or biological valve prosthesis. The cessation of coumadine in this subset of old-aged patients is, in our opinion, a major advantage. The mean age for the group I and II patients differed 4.5 years; 64.8 versus 69.3 years. This observation corroborated the assumption that mitral valve disease is related to an earlier occurrence of AF than in non-mitral valve diseased patients, in whom age is an important risk factor for the occurrence of AF (20;21).
4.2.Morbidity and mortality
The incidence postoperative complications including pulmonary complications, revisions and neurological events were similar for both groups. The euroscore for group I and II were similar; 6.2 and 5.9, although group II patients were in mean 4.5 years older. So, no additional or disproportionate induced morbidity was observed in our series.
Survival
The cumulative survival rates at 3 years were similar; 79% versus 85%. However, we observed a difference in survival of patients, who remained in AF versus those who converted into SR. The mean estimated survival times (SE) for AF and SR patients were 64.3 (2.5) versus 45.1 (4.3) months (P=0.03). However 8.0% (7/87) of the patients, who had a stable SR and 19.7% (8/41) of the AF patients died within the first 6 postoperative months. The interpretation of this observation remains unclear. The mean age, left atrial diameter, euroscore, left ventricular ejection fraction, aortic cross clamp time did not reveal any difference (Table 3) . But, the limited number of study patients potentially impedes the detection of any difference. The type of procedure, mitral-versus non-mitral surgery, was also not associated with the SR conversion rate (Fischer Exact test; p=0.45). Nevertheless, it still remains possible that patients who remained in AF might have been more sick and morbid and therefore did not convert into SR. or AF was, indeed, associated with a higher mortality rate due to its complications. Figure 4 shows the cumulative survival rates of patients in SR and AF, who had a minimal follow-up of 3 months; 0.94 versus 0.81. In conclusion, a concomitant anti-arrhythmic procedure in CABG and AVR patients is as effective as in mitral valve patients, although these patients tend to be older, but with a smaller left atrial size.
